Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001972481-25-000128
Filing Date
2025-06-25
Accepted
2025-06-25 16:05:53
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2961
  Complete submission text file 0001972481-25-000128.txt   4502
Mailing Address 9713 KEY WEST AVENUE, SUITE 400 ROCKVILLE MD 20850
Business Address 9713 KEY WEST AVENUE, SUITE 400 ROCKVILLE MD 20850 301-517-5556
MAXCYTE, INC. (Subject) CIK: 0001287098 (see all company filings)

EIN.: 522210438 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-40674 | Film No.: 251073686
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)

Mailing Address 3928 POINT EDEN WAY HAYWARD CA 94545
Business Address
Hemrajani Rekha (Reporting) CIK: 0001771213 (see all company filings)

Type: 144